How Can US FDA Bolster Drug Development? The Agency Wants Your Advice
Public meeting scheduled for November to seek recommendations for policies that FDA could implement short-term to promote drug development programs.
You may also be interested in...
Center for Drug Evaluation and Research Director Janet Woodcock continues to promote innovation in clinical trial design with a review of master protocols in the New England Journal of Medicine.